Your browser doesn't support javascript.
loading
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer.
Kanesvaran, R; Castro, E; Wong, A; Fizazi, K; Chua, M L K; Zhu, Y; Malhotra, H; Miura, Y; Lee, J L; Chong, F L T; Pu, Y-S; Yen, C-C; Saad, M; Lee, H J; Kitamura, H; Prabhash, K; Zou, Q; Curigliano, G; Poon, E; Choo, S P; Peters, S; Lim, E; Yoshino, T; Pentheroudakis, G.
Affiliation
  • Kanesvaran R; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Oncology Academic Programme, Duke-NUS Medical School, Singapore, Singapore. Electronic address: ravindran.kanesvaran@singhealth.com.sg.
  • Castro E; Department of Medical Oncology, Virgen de la Victoria University Hospital, Institute of Biomedical Research in Málaga, Malaga, Spain.
  • Wong A; Division of Medical Oncology, National University Cancer Institute, Singapore, Singapore.
  • Fizazi K; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France.
  • Chua MLK; Oncology Academic Programme, Duke-NUS Medical School, Singapore, Singapore; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore.
  • Zhu Y; Department of Urology, Fudan University, Shanghai Cancer Center, Shanghai, China.
  • Malhotra H; Department of Medical Oncology, Sri Ram Cancer Center, Mahatma Gandhi Medical College Hospital, Mahatma Gandhi University of Medical Sciences & Technology, Jaipur, India.
  • Miura Y; Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan.
  • Lee JL; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Chong FLT; Department of Radiotherapy and Oncology, Sabah Women and Children's Hospital, Kota Kinabalu, Malaysia.
  • Pu YS; Department of Urology, National Taiwan University Hospital, Taipei, Taiwan.
  • Yen CC; Division of Clinical Research, Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan; Division of Medical Oncology, Center for Immuno-oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan; National Yang Ming Chiao Tung University School of Medi
  • Saad M; Department of Clinical Oncology, University of Malaya Medical Centre, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
  • Lee HJ; Department of Medical Oncology, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, South Korea.
  • Kitamura H; Department of Urology, Faculty of Medicine, University of Toyama, Toyama, Japan.
  • Prabhash K; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India.
  • Zou Q; Department of Urology, Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
  • Curigliano G; European Institute of Oncology, IRCCS and University of Milano, Milan, Italy.
  • Poon E; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Choo SP; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Medical Oncology, Curie Oncology, Singapore, Singapore.
  • Peters S; Oncology Department, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
  • Lim E; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Yoshino T; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Pentheroudakis G; ESMO, Lugano, Switzerland.
ESMO Open ; 7(4): 100518, 2022 08.
Article in En | MEDLINE | ID: mdl-35797737
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Medical Oncology Type of study: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Male Country/Region as subject: Asia / Europa Language: En Journal: ESMO Open Year: 2022 Document type: Article Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Medical Oncology Type of study: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Male Country/Region as subject: Asia / Europa Language: En Journal: ESMO Open Year: 2022 Document type: Article Country of publication: Reino Unido